Reinhold Baumgartner
Research Subjects
Research Interests
Reinhold Baumgartner has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Gamarra
Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V, Thoracic Oncology Centre Munich, Ludwig-Maximilians-Universität München, Munich, Germany
1 shared publication - Herbert Stepp
Laser-Forschungslabor, LIFE Center, University Hospital, LMU Munich, 81377 Munich, Germany
1 shared publication - Hubert Hautmann
Medizinische Klinik I, Klinikum rechts der Isar, Technische Universität, D-81675 Munich, Germany
1 shared publication - Josef P Pichler
Laser-Forschungslabor an der Urologischen Klinik Großhadern, D-81377 Munich, Germany
1 shared publication - Rudolf Maria Huber
Division of Respiratory Medicine and Thoracic Oncology, Department of Medicine V, Ludwig-Maximilians-University of Munich, Thoracic Oncology Centre Munich, German Centre for Lung Research (DZL CPC-M), Munich, Germany
1 shared publication
Latest Publications
- Open Access
- 19 April 2007
- Published by Springer Nature in Respiratory Research
- Vol. 8 (1) , 33
In-vivo kinetics of inhaled 5-Aminolevulinic acid-Induced Protoporphyrin IX fluorescence in bronchial tissue
In the diagnosis of early-stage lung cancer photosensitizer-enhanced fluorescence bronchoscopy with inhaled 5-aminolevolinic acid (5-ALA) increases sensitivity when compared to white-light bronchoscopy. This investigation was to evaluate the in vivo tissue pharmacokinetics of inhaled 5-ALA within the bronchial mucosa in order to define the time optimum for its application prior to bronchoscopy.
- 19 April 2007
- Published by Springer Nature in Respiratory Research
- Vol. 8 (1) , 33
Open AccessIn-vivo kinetics of inhaled 5-Aminolevulinic acid-Induced Protoporphyrin IX fluorescence in bronchial tissue
In the diagnosis of early-stage lung cancer photosensitizer-enhanced fluorescence bronchoscopy with inhaled 5-aminolevolinic acid (5-ALA) increases sensitivity when compared to white-light bronchoscopy. This investigation was to evaluate the in vivo tissue pharmacokinetics of inhaled 5-ALA within the bronchial mucosa in order to define the time optimum for its application prior to bronchoscopy.